摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(6-oxo-9-((4,5,7-trimethoxy-9,10-dioxo-9,10-dihydroanthracen-2-yl)methyl)-6,9-dihydro-1H-purin-2-yl)benzamide | 1146629-19-7

中文名称
——
中文别名
——
英文名称
N-(6-oxo-9-((4,5,7-trimethoxy-9,10-dioxo-9,10-dihydroanthracen-2-yl)methyl)-6,9-dihydro-1H-purin-2-yl)benzamide
英文别名
N-(6-oxo-9-((4,5,7-trimethoxy-9,10-dioxo-9,10-dihydro-anthracen-2-yl)methyl)-6,9-dihydro-1h-purin-2-yl)-benzamide;N-[6-oxo-9-[(4,5,7-trimethoxy-9,10-dioxoanthracen-2-yl)methyl]-1H-purin-2-yl]benzamide
N-(6-oxo-9-((4,5,7-trimethoxy-9,10-dioxo-9,10-dihydroanthracen-2-yl)methyl)-6,9-dihydro-1H-purin-2-yl)benzamide化学式
CAS
1146629-19-7
化学式
C30H23N5O7
mdl
——
分子量
565.542
InChiKey
BZBGMZKAIUFQSV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    42
  • 可旋转键数:
    7
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    150
  • 氢给体数:
    2
  • 氢受体数:
    8

反应信息

  • 作为产物:
    描述:
    N-(1,6-二氢-6-氧代嘌呤-2-基)-苯甲酰胺6-Bromomethyl-1,3,8-trimethoxy-6-methyl-anthraquinonepotassium carbonate 、 potassium iodide 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以40%的产率得到N-(6-oxo-9-((4,5,7-trimethoxy-9,10-dioxo-9,10-dihydroanthracen-2-yl)methyl)-6,9-dihydro-1H-purin-2-yl)benzamide
    参考文献:
    名称:
    ω,ω′-Appended nucleo-base derivatives of hypericin
    摘要:
    omega,omega'-Disubstituted hypericin derivatives with the nucleo-bases thymine, cytosine, and adenine in these positions were prepared starting from tri-O-methyl-omega-bromoemodin. The most promising derivative proved to be that with a thymine moiety. It displayed the best solubility of the three products together with a potency to produce singlet oxygen and/or reactive oxygen species comparable to the parent compound hypericin. In addition, although no specific interaction with DNA or poly(2'-deoxyadenylic acid) could be detected, it proved to be significantly better accumulating in the nucleus of prostatic cancer LNCaP cells than hypericin making it a promising candidate for a second-generation photodynamic hypericin agent.
    DOI:
    10.1007/s00706-008-0898-0
点击查看最新优质反应信息